In focus · trending topic

hematopoietic

2 stories · following the connections

Fate Therapeutics Announces Issuance of U.S. Patent Protecting Enhanced Hematopoietic Stem Cell Compositions

By Nasdaq OMXOct 5, 2016, 12:00 PM UTC

Fate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell Transplantation

By Nasdaq OMXSep 26, 2016, 12:00 PM UTC